Beyond Steel Tanks
Codon
MARCH 24, 2024
Elliot Hershberg and Niko McCarty write about the future of biomanufacturing for Issue 02. Read this essay on our website. Novo Nordisk and Eli Lilly have struck gold. After decades of research, their GLP-1 obesity drugs appear to really work. Globally, at least 1.9 billion people are overweight, and J.P. Morgan estimates that—in the U.S. alone—about 30 million people will soon be taking weight loss drugs: Wegovy from Novo Nordisk and ZepBound from Eli Lilly.
Let's personalize your content